The invention provides a composition and method for treatment of a subjectsuffering from liver disease comprising the oral administration of a slowrelease formulation of calcium channel blocker such as diltiazem and thiaminewhich is also an antioxidant which is relatively hydrophilic when comparedwith the calcium channel blocker.